Log in to save to my catalogue

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A702014503

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

About this item

Full title

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

Publisher

Public Library of Science

Journal title

PLoS ONE, 2022, Vol.17 (4), p.e0267504

Language

English

Formats

Publication information

Publisher

Public Library of Science

More information

Scope and Contents

Contents

The efficacy and safety of disease-modifying therapies (DMTs) in multiple sclerosis (MS) are well known; however, owing to their high costs, determining real-world outcomes is essential to evaluate the cost-effectiveness of different therapeutic strategies. This study aimed to investigate the variability in the annual cost of DMTs associated with a...

Alternative Titles

Full title

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A702014503

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A702014503

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0267504

How to access this item